Variants of the PER3 gene disrupt adrenal adaptation to winter light, leading to serotonin disruption and depression-like behaviors in humanized mice models.
US Patent and Trademark Office to hear patent challenge over experimental seizure treatment
The US Patent and Trademark Office (USPTO) is taking a second look at a patent it granted Ovid Therapeutics around methods for treating seizures following
August 22, 2023